1. Eumorphia Phenotype screens for mice Developing an integrated platform

2. EUMORPHIA - the consortium  MRC Mammalian Genetics Unit, UK  IGBMC, Strasbourg, France  MRC Human Genetics Unit, UK  MRC Functional Genetics, UK  ANIMAGE, Lyon, France  CNG/CNRS Paris, France  GSF, Munich, Germany  GBF, Braunschwieg, Germany  NKI, Amsterdam, Netherlands  EMBL Monterotondo, Italy  CNR-IBC, Monterotondo, Italy  Karolinska, Stockholm, Sweden  UNIL-IBA, Lausanne, Switzerland  UNIGE, Geneva, Switzerland  Sanger Institute, Hinxton, UK  CNIO, Madrid, Spain  Univ. Manchester, UK 18 centres across Europe

3. Importance of standardisation Better reproducibility of test outcome Better comparability of test outcome Sharing of phenome results Reduction in the number of mice used in research

4. EUMORPHIA European Union Mouse Genetics Research for Public Health And Industrial Applications Phenotyping  Working groups to develop and standardise primary and secondary phenotyping protocols for all body systems  To develop them in collaboration with other centres throughout the world and in consultation with clinicians, human geneticists, physiologists and informaticians

5. Phenotyping - Workpackages  Standardisation - animal handling  Clinical Chemistry/Haematology  Renal systems  Central, peripheral nervous system, muscle  Behaviour and cognition  Imaging  Necropsy, pathology, histology  First-line phenotyping  Cardiovascular  Hormonal/metabolic  Allergy and infection  Sensory systems  Pulmonary  Cancer  Bone, Cartilage  Expression analysis European Mouse Phenotyping Resource for Standardised Screens - EMPReSS

6. What is EMPReSS? European Mouse Phenotyping Resource for Standardised Screens The EMPReSS provides a platform for the systematic and standardised primary characterisation of mouse mutant models It is a comprehensive database of validated SOPs for systematic screens and tests that allows us to describe the phenotype of a mouse

7. www.eumorphia.org

8. How was EMPReSS constructed? The SOPs are categorised according to the experience required and the amount of specialised equipment. The primary tests are divided into:  Primary - for those tests that are simple to apply and require little specialist equipment  Primary extended - which give further information on the phenotype, but require more specialised skills or equipment.

9. Working groups established SOPs discussed and drafted Validation between centres Discussion of validation results Revision of SOPs Revalidation between centres Additional validation between centres Review of SOPs by EMPReSS resource team Review and sign-off by Eumorphia scientist outside working group

10. BALB/cByJ (+ BALB/cAnN) AnN ENU mutagenesis at Harwell C57BL/6J (+ C57BL/6N) C3H/HeBFeJ (+ C3H/HeN) FeJ ENU mutagenesis at GSF/HeN at Harwell 129/SvPas (+ 129S6/SvEvTac) Inbred strains for validation

11. EMPReSS to date WP groups established March 2003 All relevant WPs have contributed A total of 161 SOPs, both primary and primary extended, have been submitted and accepted by EMPReSS along with annexes

12. Validation of the SOPs The SOPs are subjected to evaluation by one or a number of the partners. The validation levels are given at the top of each SOP Validation by testing on selected inbred mouse strains and/or selected mutants at one EUMORPHIA laboratory Validation by testing on selected inbred mouse strains and/or selected mutants at two EUMORPHIA laboratories Full comparison of results of testing on selected inbred mouse strains and/or selected mutants at more than two EUMORPHIA laboratories 35% 44% 21%

13. 0 20 40 60 80 100 CNR GSF 0 20 40 60 80 100 0 20 40 60 80 100 MRC ICS 0 20 40 60 80 100 C57BL/6 C3HeH BALB/c 129/Sv Global % PPI 0 5 10 15 20 25 30 35 0 5 10 15 20 25 30 35 0 5 10 15 20 25 30 35 40 0 3 6 9 12 15 Open field % Centre Time 1st round validation results

14. Audition and Balance Close collaboration between workpackages: 8Sensory systems 9Central/peripheral nervous and skeletal muscle systems 10Behaviour and cognition for cross lab validation, integration and ordering of the tests that cover hearing and balance. These include the modified SHIRPA, acoustic startle response, Pre-pulse Inhibition tests and the swim ability test. Open-field Modified SHIRPA Grip strength Y mazeASR & PPI Swim ability Rotarod (week 8) (week 9) (week 10)

15. Open field (week 8) I Modified SHIRPA (week 8) I Grip strength (week 8) | Rotarod (week 8) I Y maze (week 9) I PPI and ASR (week 9) I Tail Flick (week 9) | Tail Suspension (week 10) | Swim Test (week 10) Integrating and ordering tests in different systems - neurobehaviour and sensory WeekTests 8Modified SHIRPA Simple openfield Clickbox Trunk curl Limb grasping Reaching response Pinnae reflex Corneal reflex Toe pinch Air righting Contact righting Elevated platform 8Rotarod 9ASR/PPI 10Swim test

16. EUMORPHIA European Union Mouse Genetics Research for Public Health And Industrial Applications Mutagenesis Phenotyping Informatics Networking and Training

17. www.eumorphia.org

23. EMPReSS Database SOPs engineered for XML format Links between SOPs and baseline phenome data - EuroPhenome database –assisting validation, EMPReSS evaluation and SOP development EMPReSS will allow systematic integration of the ASSAY with phenotype ontologies

24. EUMORPHIA Phenotype Ontologies Informatics  We need to develop systematic and comprehensive systems to describing phenotypes - phenotype ontologies  Phenotype ontologies will be central to the development and mining of comprehensive animal phenotype databases  Integration with SOPs - the assay is central to the development of ontologies An ontology is an explicit formal specification of the terms in a domain (concepts) and the relationships (attributes) amongst them

25. Developing ontologies - the centrality of the assay CONCEPT {has_attribute} ATTRIBUTE {characterised_by} ASSAY {has_value} VALUE e.g. Eye {has_attribute} Colour {characterised_by} Visual Inspection {has_value} Brown or Mouse {has_attribute} Body Position {characterised_by} SHIRPA {has_value} Flat All phenotypes are the result of an assay

26. Building international standards Examine with our partners EMPReSS as a model to develop an international repository for SOPs and baseline data Discussions with developers, managers and users of other related resources worldwide October 2005

27. Beyond Eumorphia Primary Phenotyping EMPReSSslim Secondary Phenotyping Mouse lines EUCOMM Community Databases Mouse clinics GSF, Munich ICS, Strasbourg MRC, Harwell Sanger, Hinxton Specialist Centres Development of new technologies Bioinformatics Statistical analysis Refinement of SOPs Additional validation

28. M Dysmorphology / Blood / Metabolism Bone Allergy / Immune Cardio Sensory / Behaviour 10 weeks 14 weeks FACS analysis of peripheral blood cells Immunoglobin concentration Dysmorphology 8 weeks Clinical Chemistry X ray DEXA 12 weeks 8 weeks Opthalmoscope & Slit Lamp Acoustic Startle Tail flick Open field Modified SHIRPA Elevated Platform Grip Strength Y-maze 9 weeks 10 weeks Tail suspension Swim Ability Simplified IPGTT 13 weeks 14 weeks Non-invasive Blood Pressure Echo Cardiography ANP 9 weeks Calorimetry 10 12 weeks 10 55 33 Haematology Repeat Chemistry 10 Number of males Number of females Pipeline 1 Pipeline 2 EMPReSSslim

29. Beyond Eumorphia Primary Phenotyping EMPReSSslim Secondary Phenotyping 500? mouse lines EUCOMM Community Databases Specialist Centres Development of new technologies Bioinformatics Statistical analysis Refinement of SOPs Additional validation Mouse clinics GSF, Munich ICS, Strasbourg MRC, Harwell Sanger, Hinxton

30. Summary EMPReSS allows standardisation of primary mouse screening platforms across Europe ensuring reproducibility and comparability of functional genomics research Baseline phenome data provided through validation and SOP development will underpin mouse genetics studies Enhances efforts towards the refinement and reduction of animal use

31. EUMORPHIA - the consortium  MRC Mammalian Genetics Unit, UK  IGBMC, Strasbourg, France  MRC Human Genetics Unit, UK  MRC Functional Genetics, UK  ANIMAGE, Lyon, France  CNG/CNRS Paris, France  GSF, Munich, Germany  GBF, Braunschwieg, Germany  NKI, Amsterdam, Netherlands  EMBL Monterotondo, Italy  CNR-IBC, Monterotondo, Italy  Karolinska, Stockholm, Sweden  UNIL-IBA, Lausanne, Switzerland  UNIGE, Geneva, Switzerland  Sanger Institute, Hinxton, UK  CNIO, Madrid, Spain  Univ. Manchester, UK 18 centres across Europe